Notice of a General Meeting, to be held at the Company’s Registered Office at 9:30am on 8 October 2014 has today been sent to Shareholders and is now available from the investor section of the Sopheon website at, in the form of a circular that describes proposals for a share consolidation, in line with recent announcements from the Company. Full details of the proposed consolidation, including definitions of capitalised terms not defined in this announcement, can be found in the circular.  The proposed timetable is given below. Due to differences in the settlement mechanisms between the Netherlands and the UK, the record date set out in the proposed timetable for shares in the Netherlands is two days later than in the UK. Notwithstanding the foregoing, trading in the New Ordinary Shares will commence on both AIM and Alternext on 13 October 2014.

Date of circular 12 September 2014
Latest time and date for receipt of Proxy Forms 9.30 a.m. on 8 October 2014
General Meeting 9.30 a.m. on 10 October 2014
UK Record Date for the Share Consolidation 5.00 p.m. on 10 October 2014
Existing Ordinary Shares disabled in CREST and share register closed 5.00 p.m. on 10 October 2014
Admission effective and dealings commence in New Ordinary Shares 8.00 a.m. on 13 October 2014
CREST accounts credited with New Ordinary  Shares 13 October 2014
Netherlands Record Date for Share Consolidation 14 October 2014
Certificates in respect of New Ordinary Shares dispatched on or before 24 October 2014
Fractional payments made via CREST, or cheque despatched by 14 November 2014

For further information contact:

Barry Mence, Chairman Sopheon plc + 44 (0) 1483 685 735
Arif Karimjee, CFO Sopheon plc + 44 (0) 1483 685 735
Charlotte Stranner / Victoria Bates finnCap + 44 (0) 20 7600 1658
Heather Armstrong Newgate Threadneedle + 44 (0) 20 7653 9842
Claire Verhagen Citigate First Financial + 31 (0) 205 754 010

About Sopheon
Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability.  Sopheon’s Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle.  For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, and portfolio and in-market management.  Sopheon’s solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Alternext Exchange in the Netherlands.

Print Friendly, PDF & Email